Baird Financial »

Eyepoint Pharmaceuticals shares owned by Baird Financial

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Baird Financial from 13F filings

Historical chart of Baird Financial investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Baird Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Baird Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $250k 18k 14.24

More positions owned by Baird Financial

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Jpmorgan Chase Common (JPM)
Alphabet Inc C Common (GOOG)
Ishares Tr Rus 1000 Grw Etf Common (IWF)
Berkshire Hathaway Inc Del Cl Common (BRK.B)
Meta Platforms Inc A Common (META)
Ishares Tr Rus 1000 Val Etf Common (IWD)
Home Depot Common (HD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt Common (VEA)
Ge Aerospace Common (GE)
Ge Vernova Common (GEV)
Progressive Corp Common (PGR)
Amazon Common (AMZN)
Nvidia Corp Common (NVDA)

View all positions for Baird Financial

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
Adage Capital Partners GP
BlackRock
Federated Investors
Franklin Resources
Vanguard Group
TCG Crossover Management
Citadel Advisors
Paradigm Biocapital Advisors
OrbiMed Advisors
Geode Capital Management
Goldman Sachs Group
State Street Corporation
Essex Woodlands Health Ventures

View all funds holding Eyepoint Pharmaceuticals